Bio-Techne (TECH) EPS (Weighted Average and Diluted) (2009 - 2026)

Bio-Techne's EPS (Weighted Average and Diluted) history runs 18 years deep, the most recent figure standing at $0.32 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 128.57% year-over-year to $0.32; the TTM figure through Mar 2026 stood at $0.69 (down 16.87% YoY), while the FY2025 annual figure was $0.46, down 56.19% from the prior year.
• EPS (Weighted Average and Diluted) was $0.32 for Q1 2026 at Bio-Techne, up from $0.24 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.55 in Q3 2022 to a low of -$0.11 in Q2 2025.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.28 across 5 years, with a median of $0.31 in 2022.
• The sharpest annual moves came in 2025 and 2026: EPS (Weighted Average and Diluted) sank 142.31% in 2025, then surged 128.57% in 2026.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.31 in 2022, then tumbled by 45.16% to $0.17 in 2023, then rose by 29.41% to $0.22 in 2024, then grew by 9.09% to $0.24 in 2025, then jumped by 33.33% to $0.32 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.32 (Q1 2026), $0.24 (Q4 2025), and $0.24 (Q3 2025), per Business Quant data.